Retained EU Law SI 2020/1043 United Kingdom

Regulation (EU) 2020/1043 of the European Parliament and of the Council of 15 July 2020 on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19) (Text with EEA relevance)

Status
In Force
Penalty ceiling
Regulated

Does it bind you?

Business-side roles with duties under this instrument.

Any Person1

Other Acts binding the same actors

If a role above is yours, these are the other instruments that most often bind it.

Any Person — also bound by 2340 other Acts

What it requires

Regulations creating concrete business duties or carrying penalties, grouped as the instrument is structured. Titles link to the source text — blue means you’re leaving for legislation.gov.uk.

s.art002 (1) All operations related to the conduct of clinical trials,... Regulated
  • Sponsors must minimise environmental risks from GMO clinical trialsAny Person
4 other provisions — procedural and definitional
s.art001 For the purposes of this Regulation, the following definitions apply:...
s.art003 (1) Articles 6 to 11 and 13 to 24 of...
s.art004 (1) This Regulation shall apply as long as WHO has...
s.art005 This Regulation shall enter into force on the day following...

Duty extraction and severity labels are Guvnor’s analysis of the instrument, not the instrument itself. Always verify against the linked source text.